Main Story

The Rangers must choose between adding to their roster for a 2027 push or selling veterans to rebuild a thin farm system. Despite three straight seasons below 82 wins since their 2023 World Series title, they have enough talent to contend with targeted upgrades—but an aging core, looming departures and limited prospects make standing pat the riskiest option. The likeliest outcome: Texas buys this offseason and tries to capitalize on a changing AL West.

By the Numbers
  • Texas has not won more than 81 games in any of the three seasons since its 2023 championship.
  • The Rangers’ farm system ranks between 20th and 25th, depending on the ranking source.
  • All five of the team’s top prospects are 22 or younger; only one has played above Double-A.
  • Jacob deGrom’s and Nathan Eovaldi’s contracts could come off the books after this season.
Yes, But

Buying could make sense: Corey Seager, Wyatt Langford and a rotation led by deGrom, Eovaldi and MacKenzie Gore give Texas a credible foundation. But injuries have disrupted the lineup, the pitching staff needs reinforcements, and replacing two top starters could offset any gains. Selling would address the aging roster and weak farm system, though moving major contracts may require accepting a discount.

State of Play
  • The lineup appears close to playoff caliber, with room to add a designated hitter and a left-handed first baseman.
  • The pitching staff could use an impact starter and bullpen help.
  • Several veterans and arbitration-eligible players could leave or become more expensive over the next two seasons.
  • The author expects Texas to buy, betting that a few additions could make the Rangers a contender in the AL West.
Bottom Line

Texas has to pick a direction and commit. The roster may be too talented to tear down, but its narrow window and limited prospect depth leave little room for another half-measure: if the Rangers buy, they need to add impact pitching and get meaningful health from their core.